Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Codexis Inc (CDXS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Codexis Appoints Dr. Hicham Alaoui, Veteran Drug Discoverer, as Vice President, Biotherapeutics Research & Development

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces the appointment of Hicham Alaoui, Ph.D. to the newly created position of Vice President, Biotherapeutics Research & Development....

CDXS : 15.53 (-1.40%)
Free Technical Research on Clovis Oncology and Three More Biotech Equities

Stock Research Monitor: CLSD, CDXS, and CHRS

CDXS : 15.53 (-1.40%)
CLSD : 10.02 (-3.38%)
CLVS : 46.77 (+0.73%)
Codexis Doses First Subjects in Phase 1a Trial of CDX-6114

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it has dosed the first subjects in a first-in-human Phase 1a dose-escalation trial with CDX-6114, its orally administered...

CDXS : 15.53 (-1.40%)
New Research Coverage Highlights WPP, Codexis, Natural Resource Partners LP, Mercer International, Booking, and SINOPEC Shangai Petrochemical -- Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of WPP PLC (NYSE:WPP), Codexis,...

CDXS : 15.53 (-1.40%)
SHI : 62.31 (-0.78%)
WPP : 74.42 (-2.60%)
NRP : 32.10 (+0.78%)
MERC : 17.70 (+0.28%)
BKNG : 2,015.16 (-0.43%)
Codexis to Present at Three Upcoming Investment Conferences

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at three upcoming investment conferences:

CDXS : 15.53 (-1.40%)
Cimpress Aims to Mitigate Risks by Decentralizing Operations

Cimpress' (CMPR) management has decentralized operations to improve accountability for customer satisfaction and capital returns, simplify decision-making and improve the speed of execution.

CMPR : 150.37 (+0.59%)
CDXS : 15.53 (-1.40%)
KIGRY : 17.8100 (-3.73%)
HDS : 45.04 (+0.27%)
Here's Why You Should Add Sonoco (SON) to Your Portfolio Now

Sonoco's (SON) prospects remain bright on the back of solid earnings estimate revision activity as well as an upbeat guidance.

SON : 55.30 (+4.34%)
CDXS : 15.53 (-1.40%)
AOS : 60.11 (+0.70%)
IEX : 140.50 (+1.02%)
Codexis Reports First Quarter 2018 Financial Results

Total revenues increase 76% to $14.0 million on sharply higher R&D revenue

CDXS : 15.53 (-1.40%)
Porton Pharma Solutions and Codexis Launch Global Partnership

Codexis, Inc. (NASDAQ: CDXS) and Porton Pharma Solutions, Ltd. (SZSE: 300363) announce a strategic collaboration to deploy Codexis' world-leading biocatalyst technology within...

CDXS : 15.53 (-1.40%)
EnzymeWorks, Inc. Retracts Prior Press Release

EnzymeWorks has been ordered by the United States District Court for the Northern District of California to retract its prior statements and press releases pertaining in any way to the settlement...

CDXS : 15.53 (-1.40%)
New Research Coverage Highlights Alliance Resource Partners, MyoKardia, Pan American Silver, Stitch Fix, Codexis, and Chemical Financial -- Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Alliance Resource Partners,...

CDXS : 15.53 (-1.40%)
SFIX : 34.62 (+1.11%)
PAAS : 16.45 (+0.06%)
ARLP : 19.30 (+1.05%)
MYOK : 55.75 (-0.18%)
CHFC : 56.07 (-0.09%)
Codexis Announces Pricing of Public Offering of Common Stock

Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced the pricing of an underwritten public offering of 3,750,000 shares of its common stock at a public offering price of...

CDXS : 15.53 (-1.40%)
Codexis Announces Proposed Public Offering of Common Stock

Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares to be sold in...

CDXS : 15.53 (-1.40%)
Codexis to Present at H.C. Wainwright Global Life Sciences Conference in Monte Carlo, Monaco

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at the H.C. Wainwright Global Life Sciences Conference on Tuesday, April 10, 2018 at 9:50 a.m....

CDXS : 15.53 (-1.40%)
Origenis Appoints Dr. Peter Seufer-Wasserthal as Chief Business Officer

Origenis GmbH, a German biotech company specializing in the discovery and development of highly selective small molecule kinase inhibitors for CNS disorders, today announced the appointment...

CDXS : 15.53 (-1.40%)
XON : 14.79 (+3.07%)
Codexis, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 8, 2018 / Codexis, Inc. (NASDAQ: CDXS) will be discussing their earnings results in their Q4 Earnings Call to be held on March 8, 2018, at 4:30 PM Eastern Time.

CDXS : 15.53 (-1.40%)
Codexis to Hold 2017 Fourth Quarter and Full Year Conference Call on March 8

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report fourth quarter and full year 2017 financial results after market close on Thursday, March 8, 2018. Codexis...

CDXS : 15.53 (-1.40%)
Codexis Appoints Molecular Diagnostics Industry Veteran Shawn Clairmont to Lead High-Performance Enzymes Commercialization

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces the appointment of Shawn Clairmont to the newly created position of Senior Director, Molecular Diagnostics. Codexis is expanding...

CDXS : 15.53 (-1.40%)
Codexis to Present at the 25th International Molecular Medicine Tri-Conference

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that John Nicols, President & CEO, will discuss the development of an improved DNA ligase for the molecular diagnostics industry...

CDXS : 15.53 (-1.40%)
Codexis Reports Financial Results for the Third Quarter of 2017

Product sales increase 71% over the prior year

CDXS : 15.53 (-1.40%)

Van Meerten Stock Picks

5 Terrific Mid Caps
In this roller coaster market I wanted to find Mid Cap stocks that had consistent price appreciation over the last 6 month period.
EHC +0.99 , FTNT +0.66 , CAKE +0.95 , PLT -2.51 , AEO +0.16
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Agricharts Market Commentary

Today's Commentary

Corn futures are currently 3 to 4 cents higher in most contracts on Thursday, with help from good export sales numbers. This morning’s FAS report indicated that 640,997 MT of old crop corn was sold in the week that ended on 7/12, with 774,488 M...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar